Anastasia O. Zatolokina

Anastasia O. Zatolokina

Auto-generated profile, based on publicly available information

Anastasia O. Zatolokina

Novosibirsk State Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
TBTamara V. Belousova
Tamara V. Belousova
SLSvetlana A. Loskutova
Svetlana A. Loskutova
AZAnastasia O. Zatolokina
Anastasia O. Zatolokina
VPValeriy A. Plyushkin
Valeriy A. Plyushkin
ПАПлюшкин Валерий Александрович
Плюшкин Валерий Александрович
An analysis of the clinical situation of a 14-year-old patient with pulmonary embolism (PE) and current information on the risk factors for the development of thrombotic events are presented. Due to the presence of gynecological pathology, the girl was prescribed hormonal drugs, in particular, dydrogesterone and estrogen + gestagen. Against the background of its use, complaints of shortness of breath appeared, which was regarded as a manifestation of bronchial obstruction and bronchodilator therapy was prescribed. Due to the lack of positive dynamics during treatment, she was hospitalized. MSCT of the chest organs was performed: signs of PE were revealed; A molecular genetic study of the DNA of buccal epithelial cells (PCR) was carried out: the carriage of prothrombogenic polymorphic variants of genes of the hemostasis system was revealed, the most significant of which is a heterozygous mutation of the prothrombin FII gene (G20210A); the study of the hemostasis system revealed thrombinemia. In therapy, thrombolysis was not performed, low molecular weight heparins were prescribed the child's condition improved. The question of the need for a comprehensive examination, including research on the carriage of prothrombogenic polymorphic variants of the genes of the hemostasis system for pediatric patients in situations requiring the administration of hormonal drugs for a long course, to prevent the ocurrence of dangerous thrombotic complications, is discussed.

8 June 2024 in Pediatrics. Consilium Medicum
Verified
Journal Article
Open access
PDF file
AZAnastasia O. Zatolokina
Anastasia O. Zatolokina
SLSvetlana A. Loskutova
Svetlana A. Loskutova
TBTamara V. Belousova
Tamara V. Belousova
NBNatalia E. Blagitko
Natalia E. Blagitko
ADAnastasia M. Dagaeva
Anastasia M. Dagaeva
ХЕХрущев Сергей Евгеньевич
Хрущев Сергей Евгеньевич
Background. Chronic non-bacterial osteomyelitis (CNO) is a rare autoinflammatory bone disease that has been insufficiently studied and described in the scientific medical literature. Due to the lack of specific laboratory and instrumental criteria, a complex interdisciplinary differential diagnosis is required. Aim. To study the clinical manifestations of the onset of the disease, the features of the course, and the results of laboratory and instrumental diagnostic methods in pediatric patients living in the Novosibirsk region diagnosed with CNO. Materials and methods. A retro- and prospective observational study was conducted, and inpatient records were analyzed in patients under 18 with a documented diagnosis of CNO, SAPHO syndrome, and hospitalized in the State Novosibirsk Regional Clinical Hospital departments. Results. In the Novosibirsk region, relatively early detection of CNO is carried out, with an average diagnostic gap of about six months. Less than half (34%) of the patients from the observation group were referred to a pediatric rheumatologist at the initial visit for bone pain despite the presence of concomitant articular syndrome in most of them (70%). The most common affected area in CNO is the spine (30%), followed by the femur (19%) and pelvis (16%). Notably, at the onset of the disease, monofocal bone tissue lesions were common (52%). Pain and loss of function in the bone lesion area were typical complaints in all patients with CNO. Articular syndrome was also common. Conclusion. CNO, being a rare autoinflammatory disease, requires a relatively complex multidiscipline differential diagnosis; its outcomes largely depend on the timing of the diagnosis.

20 November 2024 in Pediatric pharmacology
Verified
Journal Article
Open access
PDF file
AZAnastasia O. Zatolokina
Anastasia O. Zatolokina
TBTamara V. Belousova
Tamara V. Belousova
SLSvetlana A. Loskutova
Svetlana A. Loskutova
NBNataliya E. Blagitko
Nataliya E. Blagitko
Background. Timely verification of the clinical diagnosis of connective tissue diseases in children based on the onset of the earliest symptoms, including skin manifestations, and timely initiation of treatment can prevent the development of irreversible complications, increase the life expectancy of patients and its quality.The aim of the study. To analyze the nature of skin manifestations as a marker of the onset connective tissue disorders, such as systemic lupus erythematosus (SLE), localized scleroderma (morphea), juvenile dermatomyositis (JDM), juvenile polyarteritis nodosa (PAN), systemic juvenile idiopathic arthritis (SJIA), and the timing of the main clinical diagnosis from the moment of manifestation of connective tissue disorders. To clearly demonstrate the importance of skin syndrome in the timeliness of clinical diagnosis, a clinical case is presented.Methods. Analysis of medical records and prospective observation of 47 patients aged up to 17 years 11 months with an established diagnosis of connective tissue diseases and the presence of skin syndrome at the onset of the disease.Results. Among patients with SLE, only 20.0% of children had skin syndrome only in the form of butterfly rash, and other skin manifestations were noted in 80.0% of patients. The period from the onset of skin syndrome to diagnosis was 8.0 ± 2.1 months. In 57.2% of patients with morphea, skin syndrome was detected exclusively in the form of single or multiple elements, and in 42.8% there was a combination of a pathognomonic morphological element with alopecia and scleroderma. The average time to make a clinical diagnosis of morphea from the onset of the skin syndrome was 11.0 ± 1.9 months. In all patients with JDM, skin manifestations were characterized by polymorphism (papules and Gottron’s sign, heliotrope rash, palmar capillaritis, livedo reticularis, cheilitis). The diagnosis was made 14.0 ± 3.2 months from the onset of skin syndrome. In patients with documented PAN, skin manifestations debuted in the form of erythema, areas of necrosis, palmar capillaritis, livedo reticularis, and cheilitis. The period from the onset of skin syndrome to clinical diagnosis was 6.0 ± 2.4 months. Among patients with SJIA, skin syndrome was represented by a maculopapular rash associated with fever and its regression when body temperature normalized. The period until clinical diagnosis was made from the onset of the skin syndrome was 2.0 ± 1.1 months.Conclusion. In most cases, the skin syndrome in patients at the onset of the disease was characterized by polymorphism and diversity of elements with the involvement of the vascular component. At the same time, the time from the debut of connective tissue disease in the form of the appearance of skin syndrome to the clinical diagnosis varied in the range from 2 to 14 months.

15 December 2023 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
TBT.V. Belousova
T.V. Belousova
SLS.A. Loskutova
S.A. Loskutova
AZA.O. Zatolokina
A.O. Zatolokina
TST.Yu. Svershchevskaya
T.Yu. Svershchevskaya
EKE.N. Kolotova
E.N. Kolotova
NCNovosibirsk Novosibirsk Oblast Regional Perinatal Center
Novosibirsk Novosibirsk Oblast Regional Perinatal Center